|GRANTWAY
EN

DEPM Prostate Cancer Research Scholarship

Monash University

Share
Favorite
Feedback
Summary
-
Rolling deadline
A$3,000
3
Bachelor
Medical and Health Sciences
Individuals
Australia
Global
New Zealand
Overview

The DEPM Prostate Cancer Research Scholarship is intended to encourage students to undertake further studies at Honours level in medicine at the Monash Alfred campus in the area of Public Health and Preventive Medicine, focusing principally on improving health outcomes for men diagnosed with prostate cancer.

Benefits

  • $3000 per annum for one year only.

Number offered

  • Three scholarships are available.

Selection criteria

  • Students will be ranked according to undergraduate results and short-listed students will be interviewed by Supervisor/s.

To retain this scholarship:

  • Maintain full-time enrolment and demonstrate satisfactory progress is being achieved. This will be determined by a brief report from the student's Honours supervisor.
Eligibility

You must be one of the following:

  • An Australian citizen
  • A New Zealand citizen
  • Australian permanent resident
  • Australian humanitarian visa holder
  • An International student

You must meet the following criteria:

  • Australian or New Zealand citizen, holder of an Australian permanent resident visa, permanent humanitarian visa or international student.
  • Obtain a minimum weighted average mark (WAM) of 70% or above, across undergraduate study in Bachelor of Medical Sciences (Honours) (MED4301 & MED4302), Bachelor of Biomedical Sciences (Honours) (BMS4100 & BMS4200), or the Bachelor of Health Sciences (Honours) (HSC4011, HSC4001 & 4002).
  • Commencing or continuing in a full-time School of Public Health and Preventive Medicine Honours program at the Monash Alfred campus (Bachelor of Medical Sciences (Honours) (MED4301 & MED4302), Bachelor of Biomedical Sciences (Honours) (BMS4100 & BMS4200), or the Bachelor of Health Sciences (Honours) (HSC4011, HSC4001 & 4002)).
Learn more or apply
All information about this funding has been collected from and belongs to the funding organization
20 April 2023